An AstraZeneca spokesperson said: “Our sympathy goes out to anyone who has lost a loved one or reported health issues. Patient care is our most sensible priority and the regulatory government has transparent and strict criteria to ensure the use of all medicines. adding vaccines. “
This follows admission by pharmaceutical company AstraZeneca that its Covid vaccines Covishield and Vaxzevria “may, in very rare cases, cause thrombotic thrombocytopenia syndrome (TTS)”.
Despite these rare events, the pharmaceutical company maintains that there is extensive knowledge from clinical trials and real global evidence that consistently supports the vaccine’s protection and efficacy. Regulatory agencies around the world continue to claim that the costs of vaccination outweigh the risks of incredibly rare side effects. .
U. K. media reports reveal that AstraZeneca made the acknowledgment in court documents related to a case alleging adverse effects, adding deaths, related to the vaccine jointly developed with the University of Oxford.
The Serum Institute of India produced the COVID-19 vaccine called Covishield, but without an mRNA platform. The viral vector platform was being prepared. In the vaccine, a chimpanzee adenovirus, ChAdOx1, was modified to allow it to carry the COVID-19 vaccine. 19 spike protein in human cells. This bloodless virus is essentially not capable of infecting the receptor, but it can teach the immune formula to prepare a mechanism opposite to such viruses.
The same generation has been used to prepare vaccines against viruses such as Ebola.
Specifically in 2023, the World Health Organization (WHO) stated in its report that TTS emerged as a new adverse event following immunization in people vaccinated with non-replicating adenovirus vector vaccines against COVID-19.
These are the AstraZeneca COVID-19 ChAdOx-1 vaccine and the Johnson vaccines
“TTS is a serious and potentially fatal adverse event. WHO has issued those interim emergency rules to raise awareness about TTS in the context of COVID-19 vaccination and to help physical care providers assess and manage potential cases of TTS,” the 2023 report. said. by the WHO read.
However, Union Health Minister Mansukh Mandaviya stated in March 2024 at the “ANI Dialogues – Navigating India’s Health Sector” that the ICMR had conducted a detailed study showing that the COVID-19 vaccine is not to blame for attacks on the facility, nor for an individual’s lifestyle and points such as excessive alcohol consumption may be just one of the causes Underlying.
Mandaviya said: “If you have a stroke today, they think it’s because of the Covid vaccine. The ICMR has carried out a detailed examination according to which the vaccine (Covid) is not to blame for the central attacks.
(with ANI entries)
© 2009-2024 Independent Press Service. All rights reserved.